American Oriental Bioengineering Announces the Inclusion of 158 Drugs in China’s National Insurance Catalog (redOrbit)

December 18th, 2009 by admin

NEW YORK, Dec. 18 /PRNewswire-Asia-FirstCall/ — American Oriental Bioengineering, Inc.

This entry was posted on Friday, December 18th, 2009 at 5:10 pm and is filed under BioEngineering, Biotechnology. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.